Bristol Myers Squibb (BMY) Change in Cash (2009 - 2026)
Bristol Myers Squibb (BMY) reported Change in Cash of -$635.0 million for Q1 2026, down 220.27% year-over-year from $528.0 million in Q1 2025, and up 88.47% on a QoQ basis from -$5.5 billion in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Change in Cash data on file, last reported at -$635.0 million in Q1 2026.
- Quarterly Change in Cash fell 220.27% year-over-year to -$635.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 billion (down 183.84% YoY) and the FY2025 annual result came in at -$129.0 million, up 88.99% from the prior year.
- Change in Cash climbed to -$635.0 million in Q1 2026 per BMY's latest filing, from -$5.5 billion in the prior quarter.
- Across five years, Change in Cash topped out at $4.0 billion in Q4 2023 and bottomed at -$5.5 billion in Q4 2025.
- The 5-year median for Change in Cash is -$623.0 million (2023), against an average of -$278.4 million.
- The widest annual swing landed in 2022, when Change in Cash tumbled 2230.26%; it then soared 286.35% in 2024.
- Tracing BMY's Change in Cash over 5 years: stood at $1.4 billion in 2022, then surged by 188.82% to $4.0 billion in 2023, then sank by 37.89% to $2.5 billion in 2024, then sank by 324.45% to -$5.5 billion in 2025, then soared by 88.47% to -$635.0 million in 2026.
- Per Business Quant, the three latest BMY Change in Cash figures stand at -$635.0 million (Q1 2026), -$5.5 billion (Q4 2025), and $3.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -1.99 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 1.98 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 4.16 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -9.29 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.91 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 65.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 563.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -635.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -635.00 Mn |
| Dec 31, 2025 | -5.51 Bn |
| Sep 30, 2025 | 3.12 Bn |
| Jun 30, 2025 | 1.74 Bn |
| Mar 31, 2025 | 528.00 Mn |
| Dec 31, 2024 | 2.45 Bn |
| Sep 30, 2024 | 1.60 Bn |
| Jun 30, 2024 | -3.04 Bn |
| Mar 31, 2024 | -2.19 Bn |
| Dec 31, 2023 | 3.95 Bn |
| Sep 30, 2023 | -857.00 Mn |
| Jun 30, 2023 | -623.00 Mn |
| Mar 31, 2023 | -277.00 Mn |
| Dec 31, 2022 | 1.37 Bn |
| Sep 30, 2022 | -3.00 Bn |
| Jun 30, 2022 | -1.62 Bn |
| Mar 31, 2022 | -1.74 Bn |
| Dec 31, 2021 | 437.00 Mn |
| Sep 30, 2021 | 2.48 Bn |
| Jun 30, 2021 | 76.00 Mn |
| Mar 31, 2021 | -3.65 Bn |
| Dec 31, 2020 | -4.89 Bn |
| Sep 30, 2020 | -502.00 Mn |
| Jun 30, 2020 | 4.12 Bn |
| Mar 31, 2020 | 3.43 Bn |
| Dec 31, 2019 | -17.67 Bn |
| Sep 30, 2019 | 2.09 Bn |
| Jun 30, 2019 | 21.07 Bn |
| Mar 31, 2019 | 424.00 Mn |
| Dec 31, 2018 | 1.50 Bn |
| Sep 30, 2018 | 409.00 Mn |
| Jun 30, 2018 | -343.00 Mn |
| Mar 31, 2018 | -79.00 Mn |
| Dec 31, 2017 | 777.00 Mn |
| Sep 30, 2017 | 1.17 Bn |
| Jun 30, 2017 | -440.00 Mn |
| Mar 31, 2017 | -327.00 Mn |
| Dec 31, 2016 | 805.00 Mn |
| Sep 30, 2016 | 498.00 Mn |
| Jun 30, 2016 | 290.00 Mn |
| Mar 31, 2016 | 259.00 Mn |
| Dec 31, 2015 | -1.59 Bn |
| Sep 30, 2015 | -224.00 Mn |
| Jun 30, 2015 | -2.10 Bn |
| Mar 31, 2015 | 723.00 Mn |
| Dec 31, 2014 | 720.00 Mn |
| Sep 30, 2014 | 569.00 Mn |
| Jun 30, 2014 | -943.00 Mn |
| Mar 31, 2014 | 1.64 Bn |
| Dec 31, 2013 | 1.82 Bn |
| Sep 30, 2013 | -50.00 Mn |
| Jun 30, 2013 | 466.00 Mn |
| Mar 31, 2013 | -301.00 Mn |
| Dec 31, 2012 | 153.00 Mn |
| Sep 30, 2012 | -1.30 Bn |
| Jun 30, 2012 | 494.00 Mn |
| Mar 31, 2012 | -3.47 Bn |
| Dec 31, 2011 | 1.31 Bn |
| Sep 30, 2011 | 806.00 Mn |
| Jun 30, 2011 | 260.00 Mn |
| Mar 31, 2011 | -1.63 Bn |
| Dec 31, 2010 | -2.55 Bn |
| Sep 30, 2010 | 1.66 Bn |
| Jun 30, 2010 | 783.00 Mn |
| Mar 31, 2010 | -2.55 Bn |
| Dec 31, 2009 | 1.32 Bn |
| Sep 30, 2009 | -1.14 Bn |